Importantly, high COTL1 expression was shown to correlate with poor disease prognosis for breast cancer and glioblastoma patients (Shao et al., 2020; Wang et al., 2022), which suggests this actin-binding protein plays a causal role in tumor progression. The gene discussed is COTL1; the disease is breast carcinoma.